Lynne Fahey McGrath, Director of Alzamend Neuro ALZN, has filed 1 purchase and 1 sale on the open market. Over the past 12 months that comes to a net sale of $69. The latest trade was on 25/10/23.

LM

LM

Lynne Fahey McGrath

Director

Company

Alzamend Neuro ALZN

First filing

23/03/23

Trades

2 trades

Buys / sales

1 / 1

12-month net buying

−$69

Last trade

25/10/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Alzamend NeuroALZN	Open-market sale	25/10/23	25/10/24	30 sh	$2.29	$68.7	−54.5%
Alzamend NeuroALZN	Open-market buy	23/03/22	23/03/23	10,000 sh	$0.44	$4,400	No record